Annex Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,020
Closed -$224K 264
2022
Q1
$224K Buy
+2,020
New +$213K 0.02% 228
2017
Q1
Sell
-9,340
Closed -$665K 123
2016
Q4
$665K Buy
9,340
+1,401
+18% +$110K 0.16% 56
2016
Q3
$686K Sell
7,939
-329
-4% -$28.7K 0.18% 53
2016
Q2
$717K Sell
8,268
-219
-3% -$17.7K 0.19% 41
2016
Q1
$636K Buy
8,487
+535
+7% +$40.3K 0.18% 51
2015
Q4
$612K Buy
7,952
+849
+12% +$63.9K 0.18% 54
2015
Q3
$475K Buy
7,103
+1,378
+24% +$101K 0.15% 62
2015
Q2
$424K Buy
5,725
+1,743
+44% +$133K 0.14% 63
2015
Q1
$311K Buy
+3,982
New +$302K 0.1% 75

Other funds holding MDT

Annex Advisory Services's MDT Position: Q2 2022 in Review

Annex Advisory Services sold out of Medtronic (MDT) in Q2 2022, closing a stake of 2,020 shares — an estimated $224K sold.

Annex Advisory Services first reported a position in MDT in Q1 2015 and held it in 9 quarters. The position peaked at $717K in Q2 2016. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Annex Advisory Services reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Annex Advisory Services sold 2,020 Medtronic shares in Q2 2022, an estimated $224K.
  • Annex Advisory Services first reported a position in Medtronic in Q1 2015 and held it in 9 quarters.
  • Annex Advisory Services's Medtronic position peaked at $717K in Q2 2016.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Annex Advisory Services's 13F filing for Q2 2022, filed 27 Jul 2022.